- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04627441
Transcutaneous and Epidural Stimulation in SCI (Service-Line)
A Pilot Study of the Characterization of Transcutaneous and Epidural Spinal Stimulation for Enabling Motor Function in Humans With Motor Complete Paraplegia
Study Overview
Status
Intervention / Treatment
Detailed Description
The study will compare motor activity and clinical outcomes over the course of TESS and EES in combination with physical rehabilitation.
The primary outcome data collected will be used to characterize and compare spinal sensorimotor activity in muscles below the level of injury during TESS and EES-enabled motor tasks in persons with chronic motor complete paralysis of the lower extremities due to traumatic SCI. Furthermore, data collected will be used as a proof of concept that TESS can be used to determine recovery of function during EES-enabled motor tasks. Following exposure to each stimulation intervention, data collection will include changes to spasticity, body composition, metabolic variables, and spinal imaging to assess the effect of either TESS or EES stimulation.
Study Type
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Spinal cord injury due to trauma located between the seventh cervical (C7) and tenth thoracic vertebrae (T10)
- American Spinal Injury Association grading scale of A or B (4 each of A and B) below the level of SCI
- Intact spinal reflexes below the level of SCI
- At least 1-year post-SCI
- At least 22 years of age
- Willing to use medically acceptable methods of contraception, if female and of child-bearing potential
Exclusion Criteria:
- Currently a prison inmate, or awaiting trial, related to criminal activity
- Pregnancy at the time of enrollment
- Dual energy x-ray absorptiometry (DEXA) t-score <-3.5 at spine and femur head
- History of chronic and/or treatment resistant urinary tract infection
- Unhealed decubitus ulcer
- Unhealed skeletal fracture
- Untreated clinical diagnosis of depression
- Presence of joint contractures or an Ashworth spasticity score of 4
- Active anti-spasticity medication regimen within 3 months prior to study enrollment
- Presence of transcranial magnetic stimulation-evoked potentials in leg muscles
- Undergoing, or planning to undergo, diathermy treatment
- Active participation in another interventional clinical trial
- Presence of conditions or disorders which require MRI monitoring
- A history of coagulopathy or other significant cardiac or medical risk factors for surgery
- Current use of a ventilator
- Clinically diagnosed cardiopulmonary complications such as chronic obstructive pulmonary disease, cardiac failure, or heart arrhythmia that contraindicate changes in body position such as supine-to-sit-to-stand activities, prolonged standing, or stepping
- Mass > 113 kg (250 pounds)
- History of frequent hypotension characterized by light headedness, or loss of consciousness
- History of frequent hypertension characterized by headache, or bradycardia
- History of frequent, severe, autonomic dysreflexia
- Any illness or condition which, based on the research team's assessment, will compromise with the patient's ability to comply with the protocol, patient safety, or the validity of the data collected during this study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: TESS-EES
Transcutaneous Electrical Spinal Stimulation (TESS), used during the first month of training sessions, followed by Epidural Electrical Stimulation (EES) during the final 6-month training period.
|
DS8R Electrical Stimulator For Human Research
Spectra WaveWriter Epidural Spinal Cord Stimulator System with CoverEdge 32 Electrode Surgical Lead
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Kinematics
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Change in measurements of joint angles, measured in degrees.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Electromyography
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Change in measurements of electrical activity at major muscle groups below the level of injury.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Foot pressure
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Change in measurements of foot pressure through shoe-insole pressure sensors.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Overground ambulation [as appropriate to the subject] (1)
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Measurement of changes in overground mobility as measured by the Modified 6 Minute Walk Test.
Trainers will assess the distance in meters which the subject can cover in 6 minutes, with a greater distance characterizing better overground mobility.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Overground ambulation [as appropriate to the subject] (2)
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Measurement of changes in walking impairment as measured by the Walking Index for Spinal Cord Injury.
Trainers will assess overall level of impairment, ranging from most severe impairment (0) to least severe impairment (20), based on the use of devices, braces, and physical assistance of one or more persons.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Somatosensory evoked potentials
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Change in measurements of change in conduction in the peripheral nerves, cervical and lumbosacral spinal cord, deep brain structures, and sensory cortex, through surface electrodes.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Transcranial magnetic stimulation motor evoked potentials
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Change in measurements of stimulus intensity required to elicit muscle responses in muscle groups known to elicit optimal motor evoked potential responses, both above and below the level of injury.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Monosynaptic spinal reflex testing
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Change in measurements of stimulation intensity H and F wave thresholds and maximal responses through surface electrodes.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Trunk stability
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Change in measurements of trunk stability using the modified functional reach test (mFRT).
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Injury severity: American Spinal Injury Association (ASIA) Impairment Scale
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Change in measurements of impairment of sensory and motor functions using the American Spinal Injury Association Impairment Scale.
Individuals are classified from A" (complete spinal cord injury) to "E" (normal function).
28 dermatomes and 10 key muscles are assessed bilaterally.
Results are summed to produce overall sensory and motor scores and are used in combination with evaluation of anal sensory and motor function as a basis for the determination of ASIA classification.
Sensory scores are rated 0 (sensation absent) to 2 (normal), bilaterally for each of 28 dermatomes.
Muscle function is rated 0 (total paralysis) to 5 (active movement, full range of motion against significant resistance) for each myotome.
Upper Extremity Motor Subscores and Lower Extremity Motor Subscores are each scored from 0 to 50; the ASIA Motor Score is scored from 0 to 100.
The presence of anal sensation and voluntary anal contraction are assessed as a yes/no.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Spasticity
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Change in measurements of spasticity using the Spinal Cord Injury Spasticity Evaluation Tool (SCI-SET).
Answers to qualitative questions are rated from -3 to +3, with a higher positive number indicating more helpful symptoms, and a lower negative number indicating more problematic symptoms.
Scores are totaled for a score which categorizes the overall positive or negative impact of a subject's spasticity symptoms.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Bone mineral density
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Measurement by dual-energy x-ray absorptiometry (DEXA) of change in bone mineral content and bone density.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Body composition - body fat mass
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Measurement by dual-energy x-ray absorptiometry (DEXA) of change in regional and total body fat mass.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Body composition - lean mass
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Measurement by dual-energy x-ray absorptiometry (DEXA) of change in regional and total lean mass.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Body composition - android and gynoid fat percentage
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Measurement by dual-energy x-ray absorptiometry (DEXA) of change in regional and total android and gynoid fat percentage.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Body composition - bone mass
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Measurement by dual-energy x-ray absorptiometry (DEXA) of change in regional and total bone mass.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Metabolics - CBC
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Measurement of changes in complete blood count with differential.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Metabolics - glucose
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Measurement of change in fasting glucose value.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Metabolics - total cholesterol
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Measurement of change in total cholesterol value.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Metabolics - HDL cholesterol
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Measurement of change in HDL cholesterol value.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Metabolics - calculated LDL cholesterol
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Measurement of change in calculated LDL cholesterol value.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Metabolics - triglycerides
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Measurement of change in triglycerides value.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Metabolics - non-HDL cholesterol
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Measurement of change in non-HDL cholesterol value.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Neurostimulator array location and migration
Time Frame: Start of EES, End month 6 EES
|
Evaluation of current array location via CT.
|
Start of EES, End month 6 EES
|
Patient-reported bowel function (1)
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Measurement of change in bowel function using the Neurogenic Bowel Dysfunction Score.
Answers to qualitative questions are rated from 0 to 5, with a higher number indicating more problematic symptoms, and totaled for a score which categorizes severity of neurogenic bowel symptoms.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Patient-reported bowel function (2)
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Measurement of change in bowel function using the International Spinal Cord Injury Bowel Function Basic Data Set (v2.0).
Answers to qualitative questions are rated from 0 to 13, with a higher number indicating more problematic symptoms, and totaled for a score which categorizes neurogenic bowel dysfunction.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Patient-reported bladder function (1)
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Measurement of change in bladder function using the Neurogenic Bladder Symptom Score.
Answers to qualitative questions are rated from 0 to 5, with a higher number indicating more problematic symptoms, and totaled for a score which categorizes severity of neurogenic bladder symptoms.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Patient-reported bladder function (2)
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Assessment of change in bowel function using the International Spinal Cord Injury Urodynamic Basic Data Set.
Data from various urodynamic variables are aggregated into a single-page format for an abstract overview of bladder dysfunction.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Male patient-reported sexual function (1)
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Assessment of change in sexual function using the International Spinal Cord Injury Male Sexual Function Basic Data Set (v2.0).
Data from various male sexual function variables are aggregated into a single-page format for an abstract overview of male sexual dysfunction.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Male patient-reported sexual function (2)
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Measurement of change in erectile dysfunction using the Sexual Health Inventory for Men (SHIM).
Answers to qualitative questions are rated from 0 to 5, with a higher number indicating better erectile function, and totaled for a score which categorizes severity of erectile dysfunction.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Male patient-reported sexual function (3)
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Measurement of change in erectile dysfunction using the International Index for Erectile Function (IIEF).
Answers to qualitative questions are rated from 0 to 5, with a higher number indicating better erectile function, and totaled for a score which categorizes severity of erectile dysfunction.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Female patient-reported sexual function (1)
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Assessment of change in sexual function using the International Spinal Cord Injury Female Sexual and Reproductive Function Basic Data Set (v2.0).
Data from various female sexual and reproductive function variables are aggregated into a single-page format for an abstract overview of female sexual and reproductive dysfunction.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Female patient-reported sexual function (2)
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Measurement of change in sexual function using the Female Sexual Function Index (FSFI).
Answers to qualitative questions are rated from 0 to 5, with a higher number indicating better sexual function, and totaled for a score which categorizes severity of sexual dysfunction.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Volitional movement (1)
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Measurement of change in volitional movement through recordings of training time in minutes.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Volitional movement (2)
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Measurement of change in volitional movement through recordings body weight support measured as a percentage of total body weight supported.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Volitional movement (3)
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Measurement of change in volitional movement through recordings of speed in miles per hour.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Volitional movement (4)
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Measurement of changes in volitional movement through recordings of assistive devices used.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Volitional movement (5)
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Measurement of changes in volitional movement through recordings of stimulator electrode location.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Volitional movement (6)
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Measurement of changes in volitional movement through recordings of stimulator intensity, measured in milliamps per volt.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Volitional movement (7)
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Measurements of changes in volitional movement through recordings of stimulator frequency measured in Hertz.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Volitional movement (8)
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Measurement of changes in volitional movement through recordings of pulse width, measured in microseconds.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Overground ambulation [as appropriate to the subject] (1)
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Measurement of changes in severity of walking impairment as measured by the Walking Index for Spinal Cord Injury (WISCI II).
Trainers combine the type of assistive device(s) used, use or no use of orthotic braces, number of persons assisting ambulation, and distance subject is able to walk (up to 10 meters), into a single score ranging from 0 to 20, with a lower number indicating more severe impairment.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Overground ambulation [as appropriate to the subject] (2)
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Measurement of changes in overground mobility as measured by the Modified 6 Minute Walk Test.
Trainers will assess the distance in meters which the subject can cover in 6 minutes, with a greater distance characterizing better overground mobility.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Overground ambulation [as appropriate to the subject] (3)
Time Frame: Baseline, End of TESS, Start of EES, End month 6 EES
|
Measurement of changes in overground mobility as measured by the Modified Timed Up and Go test.
Trainers will assess the time it takes, in minutes and seconds, for the subject to stand from a chair, move out to a 3 meter distance, return to the chair and sit down.
Less time will characterize better overground mobility.
|
Baseline, End of TESS, Start of EES, End month 6 EES
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20-006477
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Paraplegia, Spinal
-
Mayo ClinicMinnesota Office of Higher EducationTerminatedParaplegia, Spinal | Paraplegia, Complete | Paraplegia; TraumaticUnited States
-
North Carolina State UniversityUniversity of North Carolina, Chapel Hill; U.S. National Science FoundationUnknownSpinal Cord Injuries | Paraplegia, Spinal | Paraplegia, IncompleteUnited States
-
NeuroplastActive, not recruitingSpinal Cord Injuries | Acute Spinal Cord Injury | Paraplegia, Spinal | Paraplegia; TraumaticDenmark, Spain
-
University of ManitobaRecruitingSpinal Cord Injuries | Spinal Cord Injury at C5-C7 Level | Paraplegia, Spinal | Paraplegia, IncompleteCanada
-
City University of New YorkBronx Veterans Medical Research Foundation, IncTerminatedSpinal Cord Injuries | Tetraplegia/Tetraparesis | Paraplegia, Spinal | Paraplegia, SpasticUnited States
-
MD Stem CellsEnrolling by invitationSpinal Cord Diseases | Spinal Cord Injuries | SCI - Spinal Cord Injury | Paraplegia | Spinal Cord Compression | Spinal Cord Ischemia | Paraplegia, Spinal | Paraplegia; Traumatic | Spinal Paralysis | Paraplegia/ParaparesisUnited States
-
City University of New YorkIcahn School of Medicine at Mount Sinai; Bronx Veterans Medical Research Foundation...RecruitingSpinal Cord Injuries | Tetraplegia/Tetraparesis | Paraplegia, Spinal | Paraplegia, SpasticUnited States
-
Mayo ClinicCompletedSpinal Cord Trauma | Paraplegia, SpinalUnited States
-
University of ManitobaUnknownSpinal Cord Injuries | Spinal Cord Injury Cervical | Paraplegia, Spinal
-
College of Staten Island, the City University of...CompletedSpinal Cord Injuries | Tetraplegia/Tetraparesis | Paraplegia, SpinalUnited States
Clinical Trials on Transcutaneous spinal cord stimulator
-
Mayo ClinicMinnesota Office of Higher EducationTerminatedParaplegia, Spinal | Paraplegia, Complete | Paraplegia; TraumaticUnited States
-
University of LouisvilleNational Heart, Lung, and Blood Institute (NHLBI)RecruitingRespiration Disorders | Spinal Cord InjuriesUnited States
-
James J. Peters Veterans Affairs Medical CenterRecruitingOrthostatic HypotensionUnited States
-
Stimwave TechnologiesAZ Delta; GZA Ziekenhuizen Campus Sint-AugustinusActive, not recruiting
-
Ashwin ViswanathanBoston Scientific CorporationNot yet recruitingChronic Pain | Neuropathic Pain | Pain, NeuropathicUnited States
-
The Center for Clinical Research, Winston-Salem...UnknownChronic PainUnited States
-
University of California, DavisCompletedPost-laminectomy Syndrome | Axial Back PainUnited States
-
University Hospitals Cleveland Medical CenterRecruitingLow Back Pain | LipomatosisUnited States
-
Lee Fisher, PhDNational Institute of Neurological Disorders and Stroke (NINDS)RecruitingPhantom Limb Pain | Traumatic Amputation of Lower ExtremityUnited States
-
Nevro CorpUnknown